VTR
50
-5
ED
53
-2
RL
82
3
URBN
76
10
PSA
61
-2
EL
30
-4
PSX
49
2
PBI
66
-2
MAC
65
-3
EIX
77
-3
DG
29
19
BAX
36
3
CMG
69
-3
WU
32
-2
MTB
65
-3
HUM
48
7
F
48
-3
JWN
48
2
MOS
50
7
SO
62
-2
VTR
50
-5
ED
53
-2
RL
82
3
URBN
76
10
PSA
61
-2
EL
30
-4
PSX
49
2
PBI
66
-2
MAC
65
-3
EIX
77
-3
DG
29
19
BAX
36
3
CMG
69
-3
WU
32
-2
MTB
65
-3
HUM
48
7
F
48
-3
JWN
48
2
MOS
50
7
SO
62
-2
Financhill
Back

Recursion Pharmaceuticals Stock Predictions

Buy
72

RXRX
Recursion Pharmaceuticals

Last Price:
7.09
Seasonality Move:
18.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Recursion Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 29.8% based on the past 3 years of stock performance.
  • Recursion Pharmaceuticals has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Recursion Pharmaceuticals Stock Undervalued?
    The current Recursion Pharmaceuticals [RXRX] share price is $7.07. The Score for RXRX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Recursion Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 29.8% based on the past 3 years of stock performance.

Recursion Pharmaceuticals Stock Rating

Buy
72
Recursion Pharmaceuticals (RXRX) is a Buy

Is Recursion Pharmaceuticals overpriced?

  • Recursion Pharmaceuticals has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Recursion Pharmaceuticals Stock Price History

Is RXRX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com

52-Week Data

52-Week High:
15.74
52-Week Low:
5.60

Prediction Charts

Market Cap:
2.03B
Price in USD:
7.07
Volume:
13.36M
Beta:
0.81

Technical Analysis

SMA50:
6.58
SMA100:
6.89
SMA200:
8.25
52-Wk Change:
0.28%

Stock Predictions

  • Is Recursion Pharmaceuticals stock public?
    Yes, Recursion Pharmaceuticals is a publicly traded company.
  • What is the Recursion Pharmaceuticals stock quote today?
    The Recursion Pharmaceuticals stock price is 7.07 USD today.
  • How to buy Recursion Pharmaceuticals stock online?
    You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-11 7.50 7.84 8.49 7.23
Nov-12 7.52 7.58 8.05 7.43
Nov-13 7.80 7.31 8.04 7.31
Nov-14 7.39 6.91 7.58 6.88
Nov-15 6.89 6.18 6.92 6.15
Nov-18 6.25 6.10 6.26 5.90
Nov-19 6.01 6.27 6.33 5.84
Nov-20 6.30 6.04 6.37 5.70
Nov-21 6.02 5.75 6.03 5.62
Nov-22 5.78 5.70 5.99 5.60
Nov-25 5.94 6.00 6.48 5.83
Nov-26 5.97 5.89 6.06 5.83
Nov-27 5.94 6.38 6.45 5.93
Nov-29 6.50 7.07 7.14 6.44

Recursion Pharmaceuticals Earnings

Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Recursion Pharmaceuticals Forecast Revenue Growth

Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.